Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
eye irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Justification for type of information:
Guideline study performed 2020

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2020
Report date:
2020

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Chemical structure
Reference substance name:
Dipotassium 3,4,5,6-tetrabromophthalate
EC Number:
242-604-9
EC Name:
Dipotassium 3,4,5,6-tetrabromophthalate
Cas Number:
18824-74-3
Molecular formula:
C8H2Br4O4.2K
IUPAC Name:
Dipotassium 3,4,5,6-tetrabromophthalate
Test material form:
solid
Details on test material:
Dried, water-free
Specific details on test material used for the study:
Batch LP08112019
99% purity
White powder

Test animals / tissue source

Species:
human
Details on test animals or tissues and environmental conditions:
Stratified human keratinocytes

Test system

Vehicle:
unchanged (no vehicle)
Controls:
yes
yes, concurrent positive control
yes, concurrent negative control
Amount / concentration applied:
After pre-wetting tissues with 20µl Dulbecco’s Phosphate Buffered Saline for 30 minutes ± 2 minutes, a single, topical application of approximately 50mg of neat test item was applied to the surface of the EpiOcularTM model
Duration of treatment / exposure:
6 hours ± 15 minutes, followed by a 25 minutes ± 2 minutes post-treatment immersion, and 18 hours ± 15 minutes post-treatment incubation, prior to the MTT endpoint
Number of animals or in vitro replicates:
Three tissues per condition (n=3).

Results and discussion

In vitro

Results
Irritation parameter:
other: Viabiilty index
Run / experiment:
1
Value:
ca. 2.4
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
positive indication of irritation
Other effects / acceptance of results:
Viabilty range across three replicates prior to adjustment for colour control 2.5 - 3.4
No other observations

Applicant's summary and conclusion

Interpretation of results:
Category 1 (irreversible effects on the eye) based on GHS criteria
Conclusions:
Although the study performed was planned to assess the Eye Irrit 2 - Non-Classified boundary, the severity of the results suggest that Eye Dam 1 classification is appropriate.
For this assay, viablity of < 2% is a clear sign of Eye Dam 1 and normally, results in the 2 - 10% range are likely to be Eye Dam 1.

From expert assessment, Eye Dam 1 classification has been recommended.